Literature DB >> 18165727

The High Five Process: tissue-based planning for breast augmentation.

William P Adams1.   

Abstract

Despite popularity, breast augmentation has not advanced significantly in 20 years. The re-operation data for breast augmentation has been excessive at 15% to 20% in every Federal Drug Administration pre-market approval study for the past 15 years. Recently, a more scientific approach to breast augmentation has described a true process approach to this procedure. One element, tissue-based pre-operative planning, has been shown to reduce re-operation rate to less than 3% in published peer-reviewed studies. The High Five process was published in 2005 and codifies the 5 most important pre-operative decisions made during a breast augmentation procedure. Application into clinical practice of this planning system is discussed.

Mesh:

Year:  2007        PMID: 18165727     DOI: 10.1097/01.PSN.0000306185.95812.c3

Source DB:  PubMed          Journal:  Plast Surg Nurs        ISSN: 0741-5206


  4 in total

Review 1.  Decisional pathways in breast augmentation: how to improve outcomes through accurate pre-operative planning.

Authors:  Maurizio B Nava; Nicola Rocco; Gianfranco Tunesi; Giuseppe Catanuto; Alberto Rancati; Julio Dorr
Journal:  Gland Surg       Date:  2017-04

2.  A decision-making method for breast augmentation based on 25 years of practice.

Authors:  Maurizio Bruno Nava; Giuseppe Catanuto; Nicola Rocco
Journal:  Arch Plast Surg       Date:  2018-03-05

Review 3.  Lightweight breast implants: a novel solution for breast augmentation and reconstruction mammaplasty.

Authors:  Jacky Govrin-Yehudain; Haim Dvir; Dina Preise; Orel Govrin-Yehudain; Dael Govreen-Segal
Journal:  Aesthet Surg J       Date:  2015-09-01       Impact factor: 4.283

4.  Subpectoral Implant Repositioning With Partial Capsule Preservation: Treating the Long-Term Complications of Subglandular Breast Augmentation.

Authors:  Adam T Hauch; Cameron S Francis; Jourdain D Artz; Paul E Chasan
Journal:  Aesthet Surg J Open Forum       Date:  2021-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.